200 related articles for article (PubMed ID: 16738337)
1. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.
Rajaiya J; Nixon JC; Ayers N; Desgranges ZP; Roy AL; Webb CF
Mol Cell Biol; 2006 Jun; 26(12):4758-68. PubMed ID: 16738337
[TBL] [Abstract][Full Text] [Related]
2. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
3. Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I.
Egloff AM; Desiderio S
J Biol Chem; 2001 Jul; 276(30):27806-15. PubMed ID: 11373296
[TBL] [Abstract][Full Text] [Related]
4. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.
Schmidt C; Kim D; Ippolito GC; Naqvi HR; Probst L; Mathur S; Rosas-Acosta G; Wilson VG; Oldham AL; Poenie M; Webb CF; Tucker PW
EMBO J; 2009 Mar; 28(6):711-24. PubMed ID: 19214191
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.
Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA
J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822
[TBL] [Abstract][Full Text] [Related]
6. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.
Sacristán C; Tussié-Luna MI; Logan SM; Roy AL
J Biol Chem; 2004 Feb; 279(8):7147-58. PubMed ID: 14623887
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.
Nixon JC; Ferrell S; Miner C; Oldham AL; Hochgeschwender U; Webb CF
J Immunol; 2008 Nov; 181(10):6913-22. PubMed ID: 18981111
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor, Bright, and immunoglobulin heavy chain expression.
Webb CF
Immunol Res; 2001; 24(2):149-61. PubMed ID: 11594453
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations.
Nixon JC; Rajaiya JB; Ayers N; Evetts S; Webb CF
Cell Immunol; 2004 Mar; 228(1):42-53. PubMed ID: 15203319
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
12. Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes.
Hirano M; Kikuchi Y; Nisitani S; Yamaguchi A; Satoh A; Ito T; Iba H; Takatsu K
Int Immunol; 2004 May; 16(5):747-57. PubMed ID: 15096481
[TBL] [Abstract][Full Text] [Related]
13. Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.
Ren X; Siegel R; Kim U; Roeder RG
Mol Cell; 2011 May; 42(3):342-55. PubMed ID: 21549311
[TBL] [Abstract][Full Text] [Related]
14. REKLES is an ARID3-restricted multifunctional domain.
Kim D; Probst L; Das C; Tucker PW
J Biol Chem; 2007 May; 282(21):15768-77. PubMed ID: 17400556
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation.
Nixon JC; Rajaiya J; Webb CF
J Biol Chem; 2004 Dec; 279(50):52465-72. PubMed ID: 15456761
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.
Tidwell JA; Schmidt C; Heaton P; Wilson V; Tucker PW
Mol Immunol; 2011 Oct; 49(1-2):260-72. PubMed ID: 21955986
[TBL] [Abstract][Full Text] [Related]
17. A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.
Kim D; Tucker PW
Mol Cell Biol; 2006 Mar; 26(6):2187-201. PubMed ID: 16507996
[TBL] [Abstract][Full Text] [Related]
18. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family.
Herrscher RF; Kaplan MH; Lelsz DL; Das C; Scheuermann R; Tucker PW
Genes Dev; 1995 Dec; 9(24):3067-82. PubMed ID: 8543152
[TBL] [Abstract][Full Text] [Related]
19. Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.
Shankar M; Nixon JC; Maier S; Workman J; Farris AD; Webb CF
J Immunol; 2007 Mar; 178(5):2996-3006. PubMed ID: 17312145
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.
Sacristán C; Schattgen SA; Berg LJ; Bunnell SC; Roy AL; Rosenstein Y
Eur J Immunol; 2009 Sep; 39(9):2584-95. PubMed ID: 19701889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
